Antonino Catanzaro, M.D., has received nearly $2.5 million in funding from the National Institute of Allergy and Infectious Diseases (NIAID) for a 5-year international collaborative study of extensively drug resistant tuberculosis.Dr. Catanzaro, Professor of Medicine in the Division of Pulmonary and Critical Care Medicine, specializes in chronic pulmonary diseases, particularly tuberculosis.
Extensively drug resistant tuberculosis, which has a high fatality rate, is considered a global threat to tuberculosis control. Rapid detection and treatment are crucial, but current detection methods can take as long as three months.
Dr. Catanzaro and his multidisciplinary team of investigators will develop and evaluate three rapid new testing methods. In addition, they will analyze samples to correlate genetic variations with resistance to anti-tuberculosis drugs in populations in India, South Africa, Moldova, and the Philippines.
The project is “Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant Tuberculosis.” I Read the abstract of Dr. Catanzaro’s grant